| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
phenotype | 0.310 | None | 1.000 | 1 | 0 | 1999 | 2004 | ||||||||
|
ATP binding cassette subfamily G member 2 (Junior blood group) | 0.419 | 0.885 | 2.1E-32 |
|
phenotype | 0.030 | None | 1.000 | 1 | 0 | 2003 | 2008 | ||||||||
|
ALK receptor tyrosine kinase | 0.396 | 0.846 | 3.2E-06 |
|
phenotype | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2009 | ||||||||
|
PKHD1 ciliary IPT domain containing fibrocystin/polyductin | 0.576 | 0.654 | 1.2E-47 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta | 0.319 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
platelet derived growth factor receptor beta | 0.416 | 0.846 | 0.90 |
|
phenotype | 0.010 | None | < 0.001 | 1 | 0 | 2016 | 2016 | ||||||||
|
glycerophosphodiester phosphodiesterase 1 | 0.481 | 0.808 | 6.1E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2013 | 2013 | ||||||||
|
transcription factor Dp family member 3 | 0.751 | 0.385 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
lymphoid enhancer binding factor 1 | 0.486 | 0.769 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
opioid receptor kappa 1 | 0.555 | 0.615 | 4.1E-05 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
receptor tyrosine kinase like orphan receptor 1 | 0.552 | 0.731 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
neurotrophin 3 | 0.519 | 0.808 | 0.93 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
nerve growth factor | 0.391 | 0.885 | 0.82 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
PLAG1 zinc finger | 0.493 | 0.808 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
toll like receptor 9 | 0.411 | 0.885 | 9.8E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
opsin 1, long wave sensitive | 0.497 | 0.808 | 0.98 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
chronic lymphocytic leukemia up-regulated 1 | 1.000 | 0.115 | 1.7E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 5A | 0.711 | 0.423 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2014 | 2014 | |||||||||
|
poly(rC) binding protein 4 | 0.523 | 0.808 | 2.4E-03 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2012 | 2012 | ||||||||
|
diablo IAP-binding mitochondrial protein | 0.555 | 0.692 | 2.6E-06 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
protein S | 0.467 | 0.846 | 4.7E-04 |
|
phenotype | 0.010 | None | 1.000 | 1 | 0 | 2017 | 2017 |